Effect of berberine on arachidonic acid metabolism in rabbit platelets and endothelial cells

Thrombosis Research

Volumn 106, Issue 4-5, 2002, Pages 223-227

  Huang, Cai G ^a   Chu, Zhong L ^a   Wei, Shan J ^a   Jiang, Hua ^a   Jiao, Bing H ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Berberine; Cyclooxygenase; Phospholipid metabolism; Platelet aggregation; Prostacyclin; Thromboxane A2

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; BERBERINE; CALCIUM IONOPHORE; COLLAGEN; CYCLOOXYGENASE 2; MEMBRANE PHOSPHOLIPID; PROSTACYCLIN; THROMBOXANE A2; HERBACEOUS AGENT; THROMBOXANE B2;

ARACHIDONIC ACID METABOLISM; ARTICLE; BIOSYNTHESIS; BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; IN VITRO STUDY; MALE; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; RABBIT; RADIOIMMUNOASSAY; THROMBOCYTE; THROMBOCYTE AGGREGATION; ANIMAL; CYTOLOGY; GENE EXPRESSION REGULATION; METABOLISM; VASCULAR ENDOTHELIUM;

ANIMALS; ARACHIDONIC ACID; BERBERINE; BLOOD PLATELETS; DRUGS, CHINESE HERBAL; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; FEMALE; GENE EXPRESSION REGULATION; MALE; RABBITS; THROMBOXANE B2;

EID: 0037092641     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00133-0     Document Type: Article

References (52)

1. Rabbani G.H., Butler T., Knight J., Sanyal S.C., Alam K. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J. Infect. Dis. 155(5):1987;979-984.
2. Zhang M.F., Shen Y.Q. The antidiarrheal and antiinflammatory effects of berberine. Acta Pharmacol. Sin. 10(2):1989;174-176.
3. Huang C.G., Chu Z.L., Yang Z.M. The progress in pharmacological researches on berberine. Commun. Inform. Pharm. 9(4):1991;10-12.
4. Zhao X.Z., Guo X. Clinical investigation and electrocardiac physiological research of berberine. Chin. J. Cardiol. Dis. 17(3):1989;159-161.
5. Liu Y.C., Zhang J. The pharmacology and clinical application of the antiarrhythmic effect of berberine. Pharm. J. Chin. Hosp. 12(11):1992;499-500.
6. Wang C.L., He S.X., Wei F. A clinical investigation of berberine on treatment of 42 cases with hypertension. Med. J. Intern. Mong. 13(2):1993;54.
7. Yang X.J., Ni G.S. The application of berberine hydrochloride in non-infective diseases. Med. Guide. 14(5):1995;205-206.
8. Chen Q.M., Xie M.Z. Studies on the hypoglycemic effect of coptis chinesis and berberine. Acta Pharm. Sin. 21:1986;401-406.
9. Ni Y.X., Liu A.J., Gao Y.F., Wang W.H., Song Y.G., Wang L.H.et al. The efficiency of berberine on 60 cases of diabetes mellitus, type II, and laboratory investigation. CJIM. 8(12):1988;711-713.
10. Lai F.S., Wang W.C., Huang J., Chu Z.L. Effect of berberine and aspirin on blood viscosity of patients recovered from cerebral infarction. J. Clin. Geriat. 16:1996;42-43. [Special issue].
11. Chu ZL, Wang ZW, Song CQ. Antiplatelet effect of berberine and a preliminary exploration of its mechanism. Proceedings of the First National Medical Biochemistry Symposium, Shanghai, P.R. China, May 1988 (Ed. Specialized Committee of Medical Biochemistry, Chinese Biochemical Association). pp. 375-6.
12. Chu Z.L., Jiang Y.F., Wang Z.H., Song C.Q., Xu Z.P. Effects of berberine on platelet aggregation and release. Acad. J. Sec. Mil. Med. Coll. 10:1989;323-327.
13. Huang W.M., Li B.Z., Yan Z.J., Ren J.Y. Clinical and basic research on anti-platelet aggregation effect of berberine. Chin. J. Hematol. 10:1989;228-231.
14. Chu Z.L., Huang C.G., Lai F.S. The anti-platelet-rich-plasma-clot-retraction effect of berberine and its mechanism. Chin. Pharmacol. Bull. 10(2):1994;114-116.
15. Huang C.G., Chu Z.L., Yang Z.M. Effects of berberine on cytoplasmic cAMP and calcium influx of rabbit platelets. Acad. J. Sec. Mil. Med. Univ. 12(4):1991;320-322.
16. Zhao L., Feng W.H., Chu Z.L., Fan J. Preventive effect of berberine on platelet thrombosis in mice. Acad. Period Abstr. Chin. (Bull. Sci. Technol.). 3(1):1997;115.
17. Chu Z.L., Zhang T.F., Chen Y.G. The dual antiplatelet effect of berberine. Acad. Period Abstr. Chin. (Bull. Sci. Technol.). 3(4):1997;494.
18. Chu Z.L., Zhang T.F., Chen Y.G., Huang C.G. The effects of berberine and DL-tetrahydropalmatine on platelet agglutination. Int. J. Acupunct. Orient. Med. IX:1998;107-108.
19. Zhao L., Chu Z.L. The assisting effect of berberine on urokinase- and streptokinase-induced thrombolysis. Chin. Pharmacol. Bull. 14(4):1998;359-361.
20. Feng C.L., Liu S.X., Feng Q.Y., Yin J.J., Zhao L. A comparative study of antiplatelet aggregation by berberine hydrochloride with low dose aspirin. Shandong Med. 36(2):1996;11-12.
21. Giles A.R. Guidelines for the use of animals in biomedical research. Thromb. Haemost. 58(4):1987;1078-1084.
22. Chu Z.L., Chen Z.J., Zou Z.Y. Effects of pilocarpine on platelet aggregation. Acta Acad. Med. Nanjing. 7(2):1987;130-132.
23. Born G.V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 194:1962;927-929.
24. 2 in human plasma. Med. J. Chin. PLA. 10:1985;35-38.
25. 1α. Acta Acad. Med. Sin. 8:1986;310-318.
26. Chu Z.L. Biochemistry of blood cells. Liang Z.Y. Physiological Chemistry. vol. 2:1990;32-109 Shanghai Science and Technology Publisher, Shanghai.
27. Roth G.J., Stanford N., Majerus P.W. Acetylation of prostaglandin synthase by aspirin. Proc. Natl. Acad. Sci. U. S. A. 72:1975;3073-3076.
28. Burch J.W., Stanford N., Majerus P.W. Inhibition of platelet prostaglandin synthetase by oral aspirin. J. Clin. Invest. 61:1978;314-319.
29. 2-terminal serine of prostaglandin synthetase by aspirin. J. Biol. Chem. 253:1978;3782-3784.
30. Czervionke R.L., Smith J.B., Fry G.L., Hoak J.C., Haycraft D.L. Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence. J. Clin. Invest. 63:1979;1089-1092.
31. Fuster V., Chesebro J.H. Pharmacologic effects of platelet inhibitor drugs. Mayo Clin. Proc. 56(Part II):1981;185-195.
32. Vedelago H.R., Mahadevapp V.G. Mobilization of arachidonic acid in collagen-stimulated human platelets. Biochem. J. 256:1988;981-987.
33. Piche L.A., Mahadevappa V.P. Aggregation and/or oxygenated products of arachidonic acid are not required for collagen-induced deacylation of phosphatidylcholine in human platelets. Biochem. J. 263:1989;143-148.
34. Nakano T., Hanasaki K., Arita H. Possible involvement of cytoskeleton in collagen-stimulated activation of phospholipases in human platelets. J. Biol. Chem. 264(10):1989;5400-5406.
35. 2 activity in human platelets by trypsin and collagen. Arch. Biochem. Biophys. 284:1991;47-52.
36. Ferri A., Calza R. Phospholipids metabolism in platelets stimulated with collagen. Biochem. Mol. Biol. Int. 34(4):1884;693-698.
37. Caccese D., Pratico D., Ghiselli A., Natoli S., Pignatelli P., Sanguigni V.et al. Super-oxide anion and hydroxyl radical release by collagen-induced platelet aggregation. Role of arachidonic acid metabolism. Thromb. Haemost. 83:2000;485-490.
38. 2, in platelet activation in response to low concentrations of collagen. Thromb. Haemost. 85:2001;882-889.
39. Lalau Keraly C., Vickers J.D., Kinlough-Rathbone R.L., Mustard J.F. Involvement of phosphoinositide metabolism in potentiation by adrenaline of ADP-induced aggregation of rabbit platelets. Biochem. J. 242:1987;841-847.
40. Billah M.M., Lapetina E.G. Formation of lysophosphatidylinositol in platelets stimulated with thrombin or ionophore A23187. J. Biol. Chem. 257:1982;5196-5200.
41. Broekman M.J., Ward J.W., Marcus A.J. Phospholipid metabolism in stimulated human platelets. Changes in phosphatidylinositol, phosphatidic acid, and lysophospholipids. J. Clin. Invest. 66:1980;275-283.
42. Godfrey P.P., Bochner F., Grahame-Smith D.G. Dose-dependent inhibition of phosphoinositide metabolism in human platelets by aspirin in vitro and in vivo. Br. J. Clin. Pharmacol. 22940:1986;443-447.
43. Tran K., Chan A.C. Effect of vitamin E enrichment on arachidonic acid release and cellular phospholipids in cultured human endothelial cells. Biochim. Biophys. Acta. 963:1988;468-475.
44. Rubanyi G.M. The rule of endothelium in cardiovascular homeostasis and diseases. J. Cardiovasc. Pharmacol. 22(Suppl. 4):1993;s1-s14.
45. Tran K., D'Angelo A.F., Choy P.C., Chan A.C. Vitamin E enhances the activation of 1-O-alkyl-sn-glycero-3-phosphocholine in human endothelial cells. Biochem. J. 298:1994;115-119.
46. Wong J.T., Tran K., Pierce G.N., Chan A.C.O.K., Choy P.C. Lysophosphatidylcholine stimulates the release of arachidonic acid in human endothelial cells. J. Biol. Chem. 273:1998;6830-6836.
47. Wong J.T., Chan M., Lee D., Jiang J.Y., Skrzypoczak M., Choy P.C. Phosphatidylcholine metabolism in human endothelial cells: modulation by phosphocholine. Mol. Cell. Biochem. 207:2000;95-100.
48. Moncada S., Vane J.R. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N. Engl. J. Med. 300:1979;1142-1147.
49. Chierchia S., Patrono C. Role of platelet and vascular eicosanoids in the pathology of ischemic heart disease. Fed. Proc. 46:1987;81-88.
50. Fuster V., Adams P.C., Badimon J.J., Chesebro J.H. Current concepts of thrombogenesis: platelet inhibitor drugs' role in coronary artery disease. Prog. Cardiovasc. Dis. 5:1987;325-346.
51. Blackwell G.J., Dencobe W.G., Flower R.J., Parsons M.F., Vane J.R. The distribution and metabolism of arachidonic acid in rabbit platelets during aggregation and its modification by drugs. Br. J. Pharmacol. 59:1977;353-366.
52. Ingerman C.M., Smith J.B., Silver M.J. Direct measurement of platelet secretion in whole blood. Thromb. Res. 16:1979;335-344.